The Translational Research Initiative (TRI) are running a new translational support scheme

Published: 3 November 2022

The next session will take place on 24 November

The Translational Research Initiative (TRI) are running a new translational support scheme, to help researchers access critical information and resources on key regulatory requirements of their clinically-translatable projects.

This initiative aims to reduce barriers to clinical translation of innovative projects and ideas, by providing the tools and information that researchers require in order to progress their work towards clinical or commercial applications. 

The service is open for applications by researchers throughout MVLS and aims to provide access to critical information and resources, through our regulatory consultant, to support their translational research.

The service supports queries on all aspects of the regulation of clinical device and therapeutics, in Europe or the UK, including MHRA submission requirements, appropriate documentation, timescales, fees etc.

Applicants are required to complete and submit a short application to Dr Michaela Petaroudi, along with their questions for the regulatory support consultant. Successful applicants will be invited to attend either a 30-minute 1-1 session with the consultant, where they will have the opportunity to discuss their queries and receive guidance on the regulatory aspects of their translational projects, or a 1-1 longer-term support, akin to our industry mentorship scheme. In case further support is needed, eligible researchers will be offered the option to attend a follow-up session.

For any questions about this initiative or to apply, please get in touch with the Translational Research Clinical Officer, Dr Michaela Petaroudi. 

The next session will take place on 24 November 2022. 

First published: 3 November 2022